This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's Why Keurig Dr Pepper Stock is Displaying Strength
by Zacks Equity Research
Keurig Dr Pepper (KDP) benefits from positive trends in the Packaged Beverages and Coffee Systems segments due to the stay-at-home orders resulting from the pandemic.
Zacks.com featured highlights include: Keurig Dr Pepper, Bristol-Myers Squib, Vistra Energy, IHS Markit and Campbell Soup
by Zacks Equity Research
Zacks.com featured highlights include: Keurig Dr Pepper, Bristol-Myers Squib, Vistra Energy, IHS Markit and Campbell Soup
Buy These 5 Stocks With Impressive Sales Growth Right Away
by Swayta Shah
Sales growth can be considered by investors as a reliable metric for selecting profitable stocks amid the challenging operating backdrop.
Monster Beverage (MNST) Q1 Earnings Beat on Strong Top Line
by Zacks Equity Research
Monster Beverage's (MNST) first-quarter 2020 earnings benefit from sales growth in Monster Energy brand energy drinks internationally and Reign Total Body Fuel high-performance energy drinks.
Keurig Dr Pepper (KDP) Q1 Earnings & Sales Beat Estimates
by Zacks Equity Research
Keurig Dr Pepper (KDP) posts sturdy Q1 results, driven by strong sales growth across all segments.
What's in the Cards for Keurig Dr Pepper's (KDP) Q1 Earnings?
by Zacks Equity Research
Keurig Dr Pepper's (KDP) first-quarter 2020 performance is likely to reflect gains from innovation and marketing of key brands. However, growth investments are likely to entail high costs.
The Zacks Analyst Blog Highlights: Starbucks, Keurig Dr Pepper, Nestle and The J. M. Smucker Company
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Starbucks, Keurig Dr Pepper, Nestle and The J. M. Smucker Company
Surge in Coffee Prices Puts 4 Beverage Stocks in Focus
by Manaswita Ghosh Dutta
Coffee prices have received a much-needed boost as homebound consumers around the globe stock up on the beverage over fears of shortage.
Keurig Dr Pepper (KDP) Unveils Strategic Refinancing Program
by Zacks Equity Research
Keurig Dr Pepper (KDP) announces a strategic refinancing program with an aim to extend its debt maturities and enhance liquidity position.
Keurig Dr Pepper (KDP) Q4 Earnings Meet Estimates, Rise Y/Y
by Zacks Equity Research
Keurig Dr Pepper's (KDP) fourth-quarter 2019 results reflect strong underlying sales growth across all segments, margin expansion and reduced debt.
Monster Beverage (MNST) Q4 Earnings Top Estimates, Rise Y/Y
by Zacks Equity Research
Monster Beverage's (MNST) fourth-quarter 2019 results reflect strength in Monster Energy brand energy drinks.
Things to Note Ahead of Keurig Dr Pepper's (KDP) Q4 Earnings
by Zacks Equity Research
Keurig Dr Pepper's (KDP) fourth-quarter 2019 results are likely to reflect gains from acquisitions and positive effect of Allied Brands. However, unfavorable currency fluctuation remains a concern.
Coca-Cola (KO) Cheers Investors With a Hike in Dividend
by Zacks Equity Research
Coca-Cola (KO) gives investors another reason to cheer by raising its dividend for the 58th consecutive quarter. Its innovation and investment strategy place it well in the beverage industry.
Brown-Forman (BF.B) Offers a Balanced Risk-Reward Right Now
by Zacks Equity Research
Brown-Forman (BF.B) is well positioned to gain from strength across geographies and brands. However, tariff-related headwinds have been clouding its growth potential.
Diageo (DEO) Rises 22% in a Year: Will It Sustain Momentum?
by Zacks Equity Research
Diageo (DEO) displays solid momentum on strong fundamentals as well as innovation and expansion initiatives.
Coca-Cola (KO) Up 19% in a Year: What's Driving the Stock?
by Zacks Equity Research
Coca-Cola's (KO) sparkling portfolio gains from momentum in Coke Zero Sugar and other flavors. The third quarter of 2019 marked the eighth straight quarter of double-digit growth for Coke Zero Sugar.
PepsiCo's Endeavors Look Prim, What's in Store for 2020?
by Zacks Equity Research
PepsiCo's (PEP) better pricing, strength in product and geographic portfolios, product innovation, and progress on productivity targets might help retain its strong run in 2020.
Keurig Dr Pepper (KDP) Q3 Earnings and Sales Beat Estimates
by Zacks Equity Research
Keurig Dr Pepper's (KDP) top and bottom lines beat estimates in third-quarter 2019 on robust underlying sales growth, margin expansion and lower debt.
Keurig Dr Pepper (KDP) Surges: Stock Moves 5.9% Higher
by Zacks Equity Research
Keurig Dr Pepper (KDP) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
Things to Know Before Keurig Dr Pepper's (KDP) Q3 Earnings
by Zacks Equity Research
Changes in the Allied Brands portfolio and currency woes are likely to get reflected in Keurig Dr Pepper's (KDP) third-quarter sales. Higher operating income and lower debt might have aided earnings.
Zacks.com featured highlights include: Keurig Dr, Cigna, General Dynamics, Lennar and NCR
by Zacks Equity Research
Zacks.com featured highlights include: Keurig Dr, Cigna, General Dynamics, Lennar and NCR
Keurig's (KDP) Strategies to Bolster Growth: Time to Buy?
by Zacks Equity Research
Keurig (KDP) gains from acquisition and partnership strategy as well as efforts to launch innovative products and enhance supply-chain facilities. This should support growth.
PepsiCo's Smart50 Popcorn Launch Boosts Snacks Portfolio
by Zacks Equity Research
PepsiCo (PEP) launches Smart50 popcorn, which is likely to continue driving the momentum for the company's snacking business.
Attractive Sales Growth Makes These 5 Stocks Worth Buying
by Swayta Shah
Sales growth is a key measure for any company, as it is important for earnings projections and strategic decision making.
Clorox (CLX) Introduces IGNITE Strategy, Trims FY20 Guidance
by Zacks Equity Research
Clorox (CLX) introduces IGNITE strategy, which is built on a sturdy foundation of its 2020 Strategy. It aims to innovate in all areas of the business. However, management lowers view for fiscal 2020.